Expansion through acquisitions MED-EL recently acquired two gene therapy programs from Rescue Hearing Inc, signaling a strategic push to expand its genetic and molecular approach to hearing disorders. Sales opportunities may arise in partner ecosystems, clinical collaborations, and funding opportunities for gene therapy in auditory and balance disorders.

AI driven engagement With the launch of ReDi, an AI powered listening practice app, MED-EL demonstrates a commitment to digital health tools and patient engagement. This creates cross sell opportunities for telehealth enablement, app integrations, and data driven remote care solutions that can be offered to clinics and patient communities.

Remote care footprint The introduction of Remote Care and the HearCare App for cochlear implant recipients positions MED-EL favorably for remote monitoring, tele-audiology, and aftercare services. Opportunities exist to partner with clinics on remote follow ups, software subscriptions, and training programs.

Next-gen hardware upgrades Upgrading the SONNET 3 audio processor with longer life batteries and enhanced usability indicates ongoing hardware refresh cycles. This signals potential for replacements, trade-in programs, bundled service plans, and extended warranty or maintenance offerings for clinics and end users.

Global reach and partnerships Active presence in over 140 countries and recipients in more than 178 countries highlights MED-EL’s broad market access. Aligning with distributors, hospital systems, and regional clinics presents sizable sales opportunities for device adoption, training, and localized regulatory support across diverse markets.